Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Biriell

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Pharmacoepidemiology and Drug Safety|January 1, 1997
Reasons for reporting adverse drug reactions--some thoughts based on an international reviewC Biriell, I R Edwards
British Medical Journal (Clinical Research Ed.)|November 21, 1987
Skin reactions and fever with indapamideB H Stricker, C Biriell
Drug Safety|February 1, 1994
Harmonisation in pharmacovigilanceI R Edwards, C Biriell
Therapie|September 1, 1993
Sexual dysfunction as a suspected drug reaction reported to WHO Collaborating Centre for International Drug MonitoringP O Lundberg, C Biriell
BMJ (Clinical Research Ed.)|September 23, 1989
Depression associated with diltiazemC Biriell, J McEwen, E Sanz
British Medical Journal (Clinical Research Ed.)|October 5, 1985
Photosensitivity during treatment with azapropazoneS Olsson, C Biriell, G Boman
Scandinavian Journal of Immunology|October 1, 1981
Quantitation of specific IgG antibodies in rabbits by a solid-phase radioimmunoassay with 125I-protein A from Staphylococcus aureusR Lindmark, C Biriell, J Sjöquist
Drug Safety|August 17, 2000
The value of reporting therapeutic ineffectiveness as an adverse drug reactionR H Meyboom, M Lindquist, A K Flygare, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pharmacoepidemiology and Drug Safety|January 1, 1997
Reasons for reporting adverse drug reactions--some thoughts based on an international reviewC Biriell, I R Edwards
British Medical Journal (Clinical Research Ed.)|November 21, 1987
Skin reactions and fever with indapamideB H Stricker, C Biriell
Drug Safety|February 1, 1994
Harmonisation in pharmacovigilanceI R Edwards, C Biriell
Therapie|September 1, 1993
Sexual dysfunction as a suspected drug reaction reported to WHO Collaborating Centre for International Drug MonitoringP O Lundberg, C Biriell
BMJ (Clinical Research Ed.)|September 23, 1989
Depression associated with diltiazemC Biriell, J McEwen, E Sanz
British Medical Journal (Clinical Research Ed.)|October 5, 1985
Photosensitivity during treatment with azapropazoneS Olsson, C Biriell, G Boman
Scandinavian Journal of Immunology|October 1, 1981
Quantitation of specific IgG antibodies in rabbits by a solid-phase radioimmunoassay with 125I-protein A from Staphylococcus aureusR Lindmark, C Biriell, J Sjöquist
Drug Safety|August 17, 2000
The value of reporting therapeutic ineffectiveness as an adverse drug reactionR H Meyboom, M Lindquist, A K Flygare, et al.
Pageof 1